Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-01-14 Sale |
2022-01-18 9:48 pm |
Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer |
9,700 | $22.03 | $213,691 | 317,606 (Direct) |
View |
| 2021-12-21 Sale |
2021-12-23 9:03 pm |
Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer |
100 | $22 | $2,200 | 327,306 (Direct) |
View |
| 2021-12-17 Sale |
2021-12-20 4:54 pm |
Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer |
3,200 | $22.04 | $70,528 | 327,406 (Direct) |
View |
| 2021-11-01 Sale |
2021-11-03 4:15 pm |
Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer |
6,500 | $22.24 | $144,560 | 330,606 (Direct) |
View |
| 2021-10-01 Sale |
2021-10-05 4:10 pm |
Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer |
6,500 | $22.06 | $143,367 | 337,106 (Direct) |
View |
| 2021-09-01 Sale |
2021-09-03 4:38 pm |
Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer |
8,559 | $24 | $205,416 | 343,606 (Direct) |
View |
| 2021-08-02 Sale |
2021-08-04 5:39 pm |
Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer |
4,441 | $22.03 | $97,835 | 352,165 (Direct) |
View |
| 2021-07-06 Sale |
2021-07-08 7:19 pm |
Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer |
6,500 | $24.52 | $159,380 | 356,606 (Direct) |
View |
| 2021-05-03 Sale |
2021-05-04 4:06 pm |
Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer |
4,200 | $30.56 | $128,352 | 362,099 (Direct) |
View |
| 2021-04-01 Sale |
2021-04-05 5:14 pm |
Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer |
50,000 | $28.64 | $1,432,166 | 366,299 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-06-30 Option Award |
2022-09-13 9:14 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer |
1,152 | $8.03 | 91,651 (Direct) |
View |
| 2022-09-09 Option Award |
2022-09-13 9:14 pm |
N/A 2031-12-07 |
Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer |
58,148 | $0 | 91,651 (Direct) |
View |
| 2022-06-09 Option Award |
2022-06-10 5:41 pm |
N/A 2032-06-09 |
Ventyx Biosciences Inc. | VTYX | White William Richard Director |
13,301 | $0 | 13,301 (Direct) |
View |
| 2022-01-14 Exercise |
2022-01-18 9:48 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer |
9,700 | $7.009 | 317,606 (Direct) |
View |
| 2022-01-14 Exercise |
2022-01-18 9:48 pm |
N/A 2029-04-04 |
Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer |
9,700 | $0 | 317,606 (Direct) |
View |
| 2021-12-21 Exercise |
2021-12-23 9:03 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer |
100 | $7.009 | 327,306 (Direct) |
View |
| 2021-12-21 Exercise |
2021-12-23 9:03 pm |
N/A 2029-04-04 |
Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer |
100 | $0 | 327,306 (Direct) |
View |
| 2021-12-17 Exercise |
2021-12-20 4:54 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer |
3,200 | $7.009 | 327,406 (Direct) |
View |
| 2021-12-17 Exercise |
2021-12-20 4:54 pm |
N/A 2029-04-04 |
Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer |
3,200 | $0 | 327,406 (Direct) |
View |
| 2021-12-08 Option Award |
2021-12-10 5:08 pm |
N/A 2031-12-07 |
Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer |
87,221 | $0 | 87,221 (Direct) |
View |
| 2021-11-01 Exercise |
2021-11-03 4:15 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer |
6,500 | $7.009 | 330,606 (Direct) |
View |
| 2021-11-01 Exercise |
2021-11-03 4:15 pm |
N/A 2029-04-04 |
Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer |
6,500 | $0 | 330,606 (Direct) |
View |
Ownership |
2021-10-20 6:48 pm |
N/A 2031-08-17 |
Ventyx Biosciences Inc. | VTYX | White William Richard Director |
0 | $0 | 152,473 (Direct) |
View |
| 2021-10-01 Exercise |
2021-10-05 4:10 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer |
6,500 | $7.009 | 337,106 (Direct) |
View |
| 2021-10-01 Exercise |
2021-10-05 4:10 pm |
N/A 2029-04-04 |
Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer |
6,500 | $0 | 337,106 (Direct) |
View |
| 2021-09-01 Exercise |
2021-09-03 4:38 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer |
8,559 | $7.009 | 343,606 (Direct) |
View |
| 2021-09-01 Exercise |
2021-09-03 4:38 pm |
N/A 2029-04-04 |
Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer |
8,559 | $0 | 343,606 (Direct) |
View |
| 2021-08-02 Exercise |
2021-08-04 5:39 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer |
4,441 | $7.009 | 352,165 (Direct) |
View |
| 2021-08-02 Exercise |
2021-08-04 5:39 pm |
N/A 2029-04-04 |
Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer |
4,441 | $0 | 352,165 (Direct) |
View |
| 2021-07-06 Exercise |
2021-07-08 7:19 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer |
6,500 | $7.009 | 356,606 (Direct) |
View |
| 2021-07-06 Exercise |
2021-07-08 7:19 pm |
N/A 2029-04-04 |
Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer |
6,500 | $0 | 356,606 (Direct) |
View |
| 2021-05-03 Exercise |
2021-05-04 4:06 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer |
4,200 | $7.009 | 362,099 (Direct) |
View |
| 2021-05-03 Exercise |
2021-05-04 4:06 pm |
N/A 2029-04-04 |
Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer |
4,200 | $0 | 362,099 (Direct) |
View |
| 2021-04-01 Exercise |
2021-04-05 5:14 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer |
50,000 | $7.01 | 366,299 (Direct) |
View |
| 2021-04-01 Exercise |
2021-04-05 5:14 pm |
N/A 2029-04-04 |
Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer |
50,000 | $0 | 366,299 (Direct) |
View |
| 2020-06-30 Option Award |
2020-12-09 8:52 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer |
1,245 | $17.07 | 79,850 (Direct) |
View |
| 2020-12-08 Option Award |
2020-12-09 8:52 pm |
N/A 2030-12-07 |
Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer |
77,580 | $0 | 79,850 (Direct) |
View |